Gene expression alteration during redox-dependent enhancement of arsenic cytotoxicity by emodin in HeLa cells

Cell Research

Volumn 15, Issue 7, 2005, Pages 511-522

  Wang, Xiao Jing ^a   Yang, Jie ^a   Cang, Hui ^a   Zou, Yan Qiong ^a   Yi, Jing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Arsenic trioxide; Emodin; Microarray; Reactive oxygen species

Indexed keywords

ARSENIC TRIOXIDE; EMODIN; MESSENGER RNA; ORGANOARSENIC DERIVATIVE; OXIDE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; HUMAN; METABOLISM; METHODOLOGY; MICROARRAY ANALYSIS; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; TIME;

APOPTOSIS; ARSENICALS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMODIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICROARRAY ANALYSIS; OXIDATION-REDUCTION; OXIDES; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 27244437283     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290321     Document Type: Article

References (44)

1. Chen Z, Chen GQ, Shen ZX, Chen SJ, Wang ZY. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies. Semin Hematol 2001; 38:26-36.
2. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 1999; 94:2102-11.
3. Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 2003; 101:4098-104.
4. Gartenhaus RB, Prachand SN, Paniaqua M, Li Y, Gordon LI. Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: enhancement of apoptosis by manipulation of cellular redox state. Clin Cancer Res 2002; 8:566-72.
5. Gao F, Yi J, Yuan JQ, Shi GY, Tang XM. The cell cycle related apoptotic susceptibility to arsenic trioxide is associated with the level of reactive oxygen species. Cell Res 2004; 14:81-5.
6. Yi J, Gao F, Shi G, et al. The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide. Apoptosis. 2002; 7:209-15.
7. Yi J, Yang J, He R, et al. Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Cancer Res 2004; 64:108-16.
8. Yang J, Li H, Chen YY, et al. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free Radical Biol Med 2004; 37:2027-41.
9. Bode AM, Dong Z. The paradox of arsenic: molecular mechanisms of cell trans formation and chemotherapeutic effects. Crit Rev Oncol Hematol 2002; 42:5-24.
10. Chen YC, Lin-Shiau SY, Lin JK. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 1998; 177:324-33.
11. Gendron MC, Schrantz N, Metivier D, et al. Oxidation of pyridine nucleotides during Fas- and ceramide-induced apoptosis in Jurkat cells: correlation with changes in mitochondria, glutathione depletion, intracellular acidification and caspase 3 activation. Biochem J 2001; 353(Pt 2):357-67.
12. Cai X, Shen YL, Zhu Q, et al. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 2000; 14:262-70.
13. Kitamura K, Minami Y, Yamamoto K, et al. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 2000; 14:1743-50.
14. Zhu XH, Shen YL, Jing YK, et al. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst 1999; 91:772-8.
15. Chou WC, Jie C, Kenedy AA. Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci U S A. 2004; 101:4578-83.
16. Kudoh M, Knee DA, Takayama S, Reed JC. Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells. Caner Res 2002; 62:1904-9.
17. Nicholson KM, Anderson NG. The protein kinase B/AKT signalling pathway in human malignancy. Cell Signal 2002; 14:381-95.
18. Hutter D, Greene JJ. Influence of the cellular redox state on NF-kappaB-regulated gene expression. J Cell Physiol 2000; 183:45-52.
19. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003; 115:565-76.
20. Banin S, Moyal L, Shieh S, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281:1674-7.
21. Tan M, Li S, Swaroop M, et al. Transcriptional activation of the human glutathione peroxidase promoter by p53. J Biol Chem 1999; 274:12061-6.
22. Pirkkala L, Nykanen P, Sistonen L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 2001; 15:1118-31.
23. Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000; 92:1564-72.
24. Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2001; 2:67-71.
25. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, et al. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J, 2002; 21:1695-703.
26. Honore B, Vorum H. The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett 2000; 466:11-8.
27. Nickel W, Brugger B, Wieland FT. Protein and lipid sorting between the endoplasmic reticulum and the Golgi complex. Semin Cell Dev Biol 1998; 9:493-501.
28. + signaling. Curr Opin Neurobiol 1997; 7:339-45.
29. Katayama T, Imaizumi K, Sato N, et al. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol 1999; 1:479-85.
30. Patil, C, Walter P. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr Opin Cell Biol 2001; 13:349-55.
31. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001; 3:E255-63.
32. Rippo MR, Malisan F, Ravagnan L, et al. GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. FASEB J 2000; 14:2047-54.
33. Breitbart H, Spungin B. The biochemistry of the acrosome reaction. Mol Hum Reprod 1997; 3:195-202.
34. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 1996; 15:3861-70.
35. Gautier J, Minshull J, Lohka M, et al. Cyclin is a component of maturation-promoting factor from Xenopus. Cell 1990; 60:487-94.
36. Pines J, Hunter T. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol 1991; 115:1-17.
37. Erikson E, Maller JL. Biochemical characterization of the p34cdc2 protein kinase component of purified maturation-promoting factor from Xenopus eggs. J Biol Chem 1989; 264:19577-82.
38. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79:551-5.
39. Lukas J, Muller H, Bartkova J, et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 1994; 125:625-38.
40. Mills JC, Stone NL, Pittman RN. Extranuclear apoptosis. The role of the cytoplasm in the execution phase. J Cell Biol 1999; 146:703-8.
41. Coleman ML, Olson MF. Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Differ 2002; 9:493-504.
42. Carragher NO, Fincham VJ, Riley D, Frame MC. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J Biol Chem 2001; 276: 4270-5.
43. Aznar S, Lacal JC. Rho signals to cell growth and apoptosis. Cancer Lett 2001; 165:1-10.
44. Takamura M, Sakamoto M, Genda T, et al. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632. Hepatology 2001; 33:577-81.